Explore 3 Stock Ideas & Industry Insights Download Free Report

BPH Global Ltd

Company price
None AUD 0.00(0%)
Last update at 2026-11-12T06:45:02.950842Z
Market Cap
3.06M

Momentum Score

…

Ocean Sciences Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company's products include raw bird's nest and processed bird's nest products, and Caulerpa Lentillifera, sea grapes, and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries. Ocean Sciences Ltd was formerly known as BPH Global Ltd and changed its name to Ocean Sciences Ltd in September 2026. The company was incorporated in 1984 and is based in Melbourne, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.00
Low
0.02
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on BPH Global Ltd (ASX:BP8) is limited and does not clearly state its current operating business or strategy. As a small Australian-listed company, potential long-term growth would depend on clarified strategy, successful execution of any announced transactions or asset developments, and broader market conditions that may attract investors monitoring corporate updates.

Principal risks are limited public disclosure and transparency, low liquidity and higher volatility typical of small-cap ASX listings, plus execution and financing risk if the company pursues asset acquisitions or project development.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.02
Dividend Yield
-
Revenue TTM
3.44M
Revenue Per Share
0.02
Gross Profit TTM
0.06M
Debt / Equity
-0.64
ROE
-745.91%
Net Debt
0.30M
ROCE
200.84%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax -1.66M -1.49M -1.78M -3.54M -2.79M
Minority interest - - 0.18M -0.22M -0.75M
Net income -1.79M -1.49M -2.27M -4.32M -2.86M
Selling general administrative - - 0.98M 1.76M 3.13M
Selling and marketing expenses - - 0.26M - 0.18M
Gross profit -0.89M -0.68M 0.02M 0.00M 2.39M
Reconciled depreciation - - - 0.02M 0.24M
Ebit -1.77M -1.45M - -2.54M -2.73M
Ebitda -1.76M -1.45M -1.76M -2.35M -2.49M
Depreciation and amortization 0.01M 0.00M - - 0.24M
Operating income -1.77M -1.46M -1.75M -2.37M -2.73M
Other operating expenses 5.22M 1.81M 1.86M 0.00M 17.14M
Interest expense 0.09M 0.03M 0.02M - 0.06M
Tax provision - - 0.00M 0.00M 0.00M
Net interest income - - -0.02M - -0.06M
Income tax expense - - - - 0.06M
Total revenue 3.44M 0.35M 0.11M 0.00M 14.34M
Total operating expenses 0.88M 0.78M 1.77M - 5.19M
Cost of revenue 4.33M 1.03M 0.09M - 11.95M
Total other income expense net 0.11M -0.03M -0.02M -1.17M -0.06M
Discontinued operations - - - -0.57M 1.62M
Net income from continuing ops - - -1.78M -3.54M -2.79M
Net income applicable to common shares - - - -4.83M -3.54M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 1.38M 0.54M 0.28M 1.89M 7.62M
Intangible assets - - 0.00M - 0.00M
Other current assets 0.27M 0.04M - 0.00M 0.25M
Total liab 2.26M 2.01M 1.70M 1.19M 2.90M
Total stockholder equity -0.87M -1.45M -1.41M 0.53M 3.04M
Other current liab 1.44M 1.67M - 0.55M 1.64M
Common stock 82.34M 80.20M - 78.19M 76.88M
Capital stock - - 78.88M 78.28M 76.88M
Retained earnings -85.08M -83.45M -82.20M -81.31M -77.97M
Other liab - - - - -0.00M
Cash 0.26M 0.15M 0.13M 0.51M 0.62M
Cash and equivalents - - - - 0.62M
Total current liabilities 2.26M 2.01M 1.70M 1.28M 2.81M
Net debt 0.30M -0.15M 0.12M - 0.63M
Short term debt 0.56M - - - 1.16M
Short long term debt - - 0.25M - 1.09M
Short long term debt total 0.56M - - - 1.25M
Other stockholder equity - - - 3.14M -0.15M
Property plant equipment - - - 0.63M 1.71M
Total current assets 1.34M 0.54M 0.28M 0.63M 5.94M
Long term investments - - - - 0.00M
Net tangible assets - - - 0.02M 3.20M
Short term investments - - 0.00M 0.63M 0.06M
Net receivables 0.81M 0.21M - 0.02M 3.35M
Long term debt - - - - 0.04M
Inventory - 0.14M 0.05M - 1.32M
Accounts payable 0.27M 0.33M 0.00M 0.00M 0.01M
Accumulated other comprehensive income 1.88M 1.80M - - 4.29M
Non currrent assets other - - - - -0.03M
Non current assets total 0.04M 0.00M 0.00M 0.63M 1.69M
Capital lease obligations - - - - 0.12M
Long term debt total - - - - 0.09M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - - 0.19M 0.01M -0.91M
Change to liabilities - - - 0.20M -0.25M
Total cashflows from investing activities -0.01M -0.00M 0.19M -0.08M -0.91M
Net borrowings - - 0.38M -0.11M 0.28M
Total cash from financing activities 2.44M 0.96M 0.70M 1.38M 0.28M
Change to operating activities - - - 0.68M -0.18M
Net income -1.66M -1.49M -2.27M -4.83M -2.86M
Change in cash 0.11M 0.02M -0.38M -0.11M -4.63M
Begin period cash flow 0.15M 0.13M 0.51M 0.62M 5.26M
End period cash flow 0.26M 0.15M 0.13M 0.51M 0.62M
Total cash from operating activities -2.14M -0.93M - -1.34M -2.62M
Issuance of capital stock - - 0.32M 1.49M -
Depreciation 0.01M 0.00M - 0.12M 0.24M
Other cashflows from investing activities 0.01M - - - 0.00M
Change to inventory - -0.09M - -0.13M -0.61M
Change to account receivables - -0.11M - -0.49M -1.54M
Sale purchase of stock - - - - 0.00M
Other cashflows from financing activities -0.03M - - - 1.07M
Change to netincome - - - 3.10M -0.72M
Capital expenditures 0.01M 0.00M 0.00M 0.15M 0.91M
Change in working capital - 0.42M - - 0.02M
Other non cash items -0.49M 0.14M - - 2.62M
Free cash flow -2.14M -0.93M -1.26M -1.49M -3.53M

Peer Comparison*

Sector: Industry:

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CBAPI
Commonwealth Bank of Australia
0.02
0.02%
101.50 - - - - - -
RF1
Regal Investment Fund
-0.07
2.30%
2.98 - - - - - -
PCI
Perpetual Credit Income Trust
0.01
0.46%
1.08 - - - - - -
HGO
Hillgrove Resources Ltd
0.04
4.21%
1.11 0.90 3.21 1.28 2.00 1.08 4.56

Profile*

BPH Global Ltd

Ocean Sciences Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company's products include raw bird's nest and processed bird's nest products, and Caulerpa Lentillifera, sea grapes, and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries. Ocean Sciences Ltd was formerly known as BPH Global Ltd and changed its name to Ocean Sciences Ltd in September 2026. The company was incorporated in 1984 and is based in Melbourne, Australia.

365 Little Collins Street, Melbourne, VIC, Australia, 3000

61 2 9088 2049

Name Title Year Born
Mr. Huan Qing Gu CEO, MD & Director NA
Mr. Chow-Yee Koh CFO & Director 1976
Ms. Elizabeth Spooner Joint Company Sec. NA
Ms. Belinda Cleminson Joint Company Sec. NA
Mr. Francesco Cannavo Part-Time Executive Director NA
Mr. Matthew Leonard MD & Executive Director NA
Mr. Chow-Yee Koh Chief Financial Officer 1976
Mr. Francesco Cannavo Part-Time Executive Director NA
Ms. Belinda Cleminson Joint Company Secretary NA
Ms. Shelby Coleman Joint Company Secretary NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…